Can Fast Gas Chromatography Misidentify Cannabis Constituents?

Shortening a chromatographic analysis can compromise the separation needed to identify cannabis constituents correctly. A method-comparison study found a specific overlap involving derivatized THC and cannabidiolic acid under rapid conditions.

The specimen was a cannabis product

The investigators analyzed standards and forensic cannabis materials, optimized GC–MS conditions, and compared results with HPLC–DAD. These were product-composition measurements, rather than blood or urine tests from drivers.

Acidic precursors and neutral cannabinoids require careful distinction. Heating, derivatization, and chromatographic conditions can affect how the original product is represented in the result.

Why a matching retention time is insufficient

Under rapid conditions, derivatives of THC and cannabidiolic acid shared retention behavior. Broader separation conditions improved discrimination. Mass-spectral selectivity helped, but did not make resolution and method validation irrelevant.

The interlaboratory comparison also found higher CBD and THC measurements by HPLC–DAD than by GC–MS in the tested samples. This is evidence about those methods and materials; it does not establish a universal numerical correction for every laboratory.

Questions for a disputed product label

Ask how the method distinguishes each constituent, whether acidic and neutral forms were reported separately, and whether reference standards and resolving conditions match the actual sample. A high-quality calibration curve does not cure an identification problem caused by overlapping compounds.

The study supports scrutiny of rapid analytical workflows. It does not determine a consumer’s absorbed dose or impairment, and it cannot establish that any particular commercial label is wrong without testing the relevant material using a suitable validated procedure.

Identification and quantification need separate evaluation. A calibration curve can be highly linear while two constituents remain insufficiently separated. Conversely, resolving two compounds does not by itself establish accurate concentration estimates across the reporting range. The appropriate review asks which part of the method was validated for the contested conclusion.

Related reading: cannabis potency, self-titration, and measured exposure.

Primary research

Julio Salazar-Bermeo; Bryan Moreno-Chamba; María Concepción Martínez-Madrid; Manuel Valero; Joaquín Rodrigo-García; Farah Hosseinian; Francisco Martín-Bermudo; Manuel Aguado; Rosa de la Torre; Nuria Martí; Domingo Saura. Preventing Mislabeling: A Comparative Chromatographic Analysis for Classifying Medical and Industrial Cannabis. Molecules (2023). DOI: 10.3390/molecules28083552.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Plant Raman Testing for THC and CBD: Why Sampling the Right Tissue Matters

Where a Raman instrument samples a cannabis plant can determine whether it obtains useful cannabinoid information. A 42-plant study found informative THC- and CBD-related signals in glandular-trichome-rich regions, while other leaf and stem regions did not provide the same information. Why the wavelength and tissue mattered Porcu and colleagues investigated…

Spread the love

Read Article: Plant Raman Testing for THC and CBD: Why Sampling the Right Tissue Matters

Nabiximols and Urine Screening: A Dose Correlation Is Not an Impairment Measurement

A urine cannabinoid screen can correlate with a prescribed nabiximols dose without measuring impairment. In a small multiple-sclerosis study, the relationship concerned ongoing treatment exposure and laboratory response. It did not establish an acute driving-risk threshold or a way to calculate an individual’s exact dose from one specimen. Who was…

Spread the love

Read Article: Nabiximols and Urine Screening: A Dose Correlation Is Not an Impairment Measurement

Why 98.7% Fingerprint THC Agreement Needs Its Underlying Counts

A fingerprint THC screen achieved 98.7% agreement with laboratory fingerprint testing in 75 postmortem cases. The underlying counts were 73 true negatives, one true positive and one false positive. Those numbers convey much more about the evidence than the headline percentage alone. What “accuracy” referred to Hudson and colleagues evaluated…

Spread the love

Read Article: Why 98.7% Fingerprint THC Agreement Needs Its Underlying Counts

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us